Healthy men test new drug copycat in early safety study
NCT ID NCT07495930
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test a new drug called HLX319 against an already approved drug, EU-Phesgo®, in 24 healthy Chinese men. The goal is to see how the body processes each drug and check for side effects. Participants receive a single injection and are monitored closely. This research helps decide if larger studies should move forward.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Medical University Second Affiliated Hospital
Hefei, Anhui, 230601, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the right work-rest rhythm and a massage gun soften stiff calf muscles?
- Beetroot boost: does more nitrate mean more endurance?
- What makes people move? new study probes the secrets of physical activity
- New daily pill TIX100 takes first step toward tackling obesity
- New skin ointment takes first step toward treating inflammatory conditions
- One yoga session may boost heart health overnight